50-199-0087

Cul2Rabbit anti-Human, Polyclonal, Rockland™

Manufacturer: Rockland Immunochemicals

Select a Size

Pack Size SKU Availability Price
Each of 1 50-199-0087-Each-of-1 In Stock ₹ 52,930.08

50-199-0087 - Each of 1

₹ 52,930.08

In Stock

Quantity

1

Base Price: ₹ 52,930.08

GST (18%): ₹ 9,527.414

Total Price: ₹ 62,457.494

Antigen

Cul2

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Cul2

Gene Alias

1300003D18Rik; 4932411N15Rik; AI327301; CUL2; CUL-2; cullin 2; Cullin-2; MGC131970; mKIAA4106; OTTHUMP00000019437; testis secretory sperm-binding protein Li 238E

Host Species

Rabbit

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Applications

ELISA, Immunohistochemistry, Immunoprecipitation, Western Blot

Concentration

85 mg/mL

Formulation

Antibody with 0.01% sodium azide; pH

Gene Accession No.

Q13617

Gene Symbols

Cul2

Immunogen

Anti-Cul2 was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to the C-Terminus region near amino acids 720-745 of Human Cul2 coupled to KLH.

Regulatory Status

RUO

Gene ID (Entrez)

8453

Content And Storage

-20°C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Rockland Immunochemicals

50-199-0089

--

Img

Rockland Immunochemicals

50-199-0102

--

Img

Rockland Immunochemicals

50-199-0053

--

Img

Abnova Corporation

89-998-709

--

Img

Bioss

50-198-5980

--

Img

Rockland Immunochemicals

50-199-0031

--

Img

Bioss

50-198-5551

--

Img

Abbomax Inc

50-220-3996

--

Description

  • Store vial at -20°C prior to opening
  • Aliquot contents and freeze at -20°C or below for extended storage
  • Avoid cycles of freezing and thawing
  • Centrifuge product if not completely clear after standing at room temperature
  • This product is stable for several weeks at 4°C as an undiluted liquid
  • Dilute only prior to immediate use
  • This product reacts with human Cullin 2
  • Cross reactivity with Cul2 from other sources has not been determined
  • Stem cells offer a therapeutic promise for many diseases
  • In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.)
  • For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation
  • Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.